What is the treatment for laryngospasm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Laryngospasm

The treatment of laryngospasm requires a stepwise approach starting with continuous positive airway pressure with 100% oxygen while ensuring airway patency, followed by Larson's maneuver, and if unsuccessful, administration of propofol (1-2 mg/kg IV) and suxamethonium (1 mg/kg IV) for persistent cases. 1

Recognition of Laryngospasm

Laryngospasm presents with:

  • Characteristic inspiratory "crowing" sound
  • Suprasternal recession ("tracheal tug")
  • Use of accessory respiratory muscles
  • Paradoxical movements of thorax and abdomen
  • Complete obstruction may present with silent inspiration 1

If unrecognized or untreated, laryngospasm can lead to:

  • Post-obstructive pulmonary edema
  • Hypoxic cardiac arrest
  • Death 1

Immediate Management Algorithm

  1. Call for help

  2. Apply continuous positive airway pressure (CPAP) with 100% oxygen using reservoir bag and facemask

    • Ensure upper airway is patent
    • Avoid unnecessary upper airway stimulation 1
  3. Perform Larson's maneuver:

    • Place middle finger of each hand in the "laryngospasm notch" (between posterior border of mandible and mastoid process)
    • Displace mandible forward in a jaw thrust
    • Apply deep pressure at this point 1
  4. If laryngospasm persists and/or oxygen saturation is falling:

    • Administer propofol (1-2 mg/kg IV)
    • Note: Low doses may be effective in early laryngospasm, but larger doses are needed for severe laryngospasm or total cord closure 1
  5. For worsening hypoxia with continuing severe laryngospasm:

    • Administer suxamethonium 1 mg/kg IV
    • This provides cord relaxation, permitting ventilation, re-oxygenation, and intubation if necessary 1
  6. If no intravenous access:

    • Administer suxamethonium via:
      • Intramuscular route (2-4 mg/kg)
      • Intralingual route (2-4 mg/kg)
      • Intra-osseous route (1 mg/kg) 1
  7. Consider atropine to treat bradycardia (particularly important in pediatric patients) 1, 2

  8. In extreme cases, consider surgical airway 1

Alternative Approaches for Refractory Cases

For refractory laryngospasm, consider:

  • Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) - a noninvasive ventilation technique that provides apneic oxygenation and generates CPAP 3
  • Reintubation may be necessary in severe cases to maintain adequate oxygenation and ventilation 3

Prevention of Laryngospasm

Preventive measures include:

  • Performing suction under direct vision with patient deeply anesthetized
  • Avoiding stimulation until patient is awake
  • Using topical lidocaine sprayed onto vocal cords at induction
  • Considering less irritant anesthetic agents (sevoflurane and propofol)
  • Using adjuncts such as IV lidocaine, magnesium, or ketamine 1

Special Considerations

  • Pediatric patients: Higher incidence of laryngospasm (17.4/1000) compared to general population (8.7/1000) 2, 4
  • Risk factors: Smoking, pre-existing airway infections, airway manipulation, increased secretions, blood/surgical debris around glottic area 1
  • Monitoring: Watch for post-obstructive pulmonary edema, which occurs in approximately 0.1% of all general anesthetics and is most commonly caused by laryngospasm (>50% of cases) 1

Common Pitfalls

  • Delayed recognition: Laryngospasm may present atypically as airway obstruction, regurgitation/vomiting, or desaturation 5
  • Inadequate treatment: Failure to escalate treatment promptly can lead to severe hypoxemia, pulmonary aspiration, and post-obstructive pulmonary edema 5
  • Overlooking bradycardia: Particularly important in patients under 1 year of age, where bradycardia occurs in up to 23% of laryngospasm cases 5

Remember that laryngospasm is a potentially life-threatening complication that requires immediate recognition and appropriate management to prevent serious morbidity and mortality.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pediatric laryngospasm: prevention and treatment.

Current opinion in anaesthesiology, 2009

Research

Management of Refractory Laryngospasm.

Journal of voice : official journal of the Voice Foundation, 2021

Research

Crisis management during anaesthesia: laryngospasm.

Quality & safety in health care, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.